These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 155768)

  • 41. Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum.
    Lal S; De la Vega CE; Sourkes TL; Friesen HG
    J Clin Endocrinol Metab; 1973 Nov; 37(5):719-24. PubMed ID: 4749446
    [No Abstract]   [Full Text] [Related]  

  • 42. Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey.
    Diefenbach WP; Carmel PW; Frantz AG; Ferin M
    J Clin Endocrinol Metab; 1976 Sep; 43(3):638-42. PubMed ID: 821963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of quin 2 to measure calcium concentrations in ovine anterior pituitary cells and the effects of quin 2 on secretion of growth hormone and prolactin.
    Hart GR; Ray KP; Wallis M
    FEBS Lett; 1986 Jul; 203(1):77-81. PubMed ID: 3087782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide.
    Bowers CY; Friesen HG; Hwang P; Guyda HJ; Folkers K
    Biochem Biophys Res Commun; 1971 Nov; 45(4):1033-41. PubMed ID: 5000704
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of thyrotropin-releasing hormone on prolactin, growth hormone and corticosterone secretions in adult male rats treated with pentobarbital or morphine.
    Collu R; Clermont MJ; Ducharme JR
    Eur J Pharmacol; 1976 May; 37(1):133-40. PubMed ID: 819277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of hypothalamic dopamine on growth hormone-releasing hormone-induced growth hormone secretion and thyrotropin-releasing hormone-induced prolactin secretion in goats.
    Jin J; Hashizume T
    Anim Sci J; 2015 Jun; 86(6):634-40. PubMed ID: 25442325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone].
    Boiadzhieva N; Zakharieva B; Ovcharov R
    Eksp Med Morfol; 1985; 24(1):29-32. PubMed ID: 3928331
    [No Abstract]   [Full Text] [Related]  

  • 48. Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.
    Hall R; Besser GM; Schally AV; Coy DH; Evered D; Goldie DJ; Kastin AJ; McNeilly AS; Mortimer CH; Phenekos C; Tunbridge WM; Weightman D
    Lancet; 1973 Sep; 2(7829):581-4. PubMed ID: 4125377
    [No Abstract]   [Full Text] [Related]  

  • 49. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
    Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y
    J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyrotropin and prolactin inhibitory studies by compounds related to the thyrotropin releasing hormone.
    Sievertsson H; Castensson S; Andersson K; Björkman S; Bowers CY
    Biochem Biophys Res Commun; 1975 Oct; 66(4):1401-7. PubMed ID: 811221
    [No Abstract]   [Full Text] [Related]  

  • 51. Prolactin and growth hormone in the unstressed Brattleboro rat.
    Adler RA; Sokol HW
    Ann N Y Acad Sci; 1982; 394():607-13. PubMed ID: 6817681
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of pretreatment with tetradecanoyl phorbol acetate on regulation of growth hormone and prolactin secretion from ovine anterior pituitary cells.
    Boyd RS; Wallis M
    FEBS Lett; 1989 Jul; 251(1-2):99-103. PubMed ID: 2546831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of prolactin and TSH secretion by continuous infusion of small amounts of thyrotropin-releasing hormone (TRH).
    Noel GL; Dimond RC; Wartofsky L; Earll JM; Frantz AG
    J Clin Endocrinol Metab; 1974 Jul; 39(1):6-17. PubMed ID: 4209924
    [No Abstract]   [Full Text] [Related]  

  • 54. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal prolactin and growth hormone responses to thyrotropin releasing hormone in chronic alcoholic men.
    Van Thiel DH; Smith WI; McClain CJ; Lester R
    Curr Alcohol; 1979; 5():71-9. PubMed ID: 114360
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
    Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
    [No Abstract]   [Full Text] [Related]  

  • 58. Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction.
    Borzio M; Caldara R; Ferrari C; Barbieri C; Borzio F; Romussi M
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):441-7. PubMed ID: 7270004
    [No Abstract]   [Full Text] [Related]  

  • 59. Growth hormone, thyrotropin, and prolactin responses to thyrotropin-releasing hormone following diethylstilbestrol pretreatment.
    Carlson HE; Jacobs LS; Daughaday WH
    J Clin Endocrinol Metab; 1973 Sep; 37(3):488-90. PubMed ID: 4206493
    [No Abstract]   [Full Text] [Related]  

  • 60. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.